2019 top news stories
Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first...
Read More...
Trending menu:
-
![Lilly, Boehringer begin EMPULSE study of Jardiance in heart failure]()
November’s top news stories
Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether...
Read More...
-
![eTMF Cancer Research]()
Exploring efficiencies from eTMF with Cancer Research UK
Creating electronic versions of documents and processes underlying clinical trials is becoming the norm. Cancer...
Read More...
-
![GSK initiates Phase III programme of gepotidacin antibiotic]()
October’s top news stories
GSK has initiated the Phase III EAGLE programme of gepotidacin for the treatment of uncomplicated...
Read More...
-
![]()
September’s top news stories
NIH kick starts hunt for neuroprotective stroke treatments and Denali begins dosing Parkinson’s patients in...
Read More...
-
![]()
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet...
Read More...
-
![]()
June’s top news stories
AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial...
Read More...
-
![]()
May’s top news stories
Novartis reported that the first clinical trial in its Phase III PLATINUM programme for QMF149...
Read More...
-
![]()
April’s top news stories
Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech company MorphoSys have begun the first...
Read More...
-
![]()
March’s top news stories
Aldeyra Therapeutics reported positive data from the Phase III ALLEVIATE trial that evaluated the efficacy...
Read More...
